Table 3.
Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|
OR | CI | P | OR | CI | P | |
Age | 1.05 | 1.03–1.06 | <0.01 | 1.05 | 1.03–1.07 | <0.01 |
Male | 0.83 | 0.63–1.10 | 0.20 | |||
HT | 0.77 | 0.58–1.02 | 0.07 | 0.82 | 0.48–1.40 | 0.47 |
DM | 0.59 | 0.43–0.82 | <0.01 | 0.65 | 0.37–1.16 | 0.14 |
HL | 0.48 | 0.36–0.66 | <0.01 | 0.55 | 0.33–0.93 | 0.02 |
AF | 6.57 | 4.90–8.80 | <0.01 | 4.71 | 3.89–7.67 | <0.01 |
LVEDV | 1.00 | 1.00–1.01 | 0.07 | 1.02 | 1.00–1.03 | 0.02 |
LV mass | 1.00 | 0.99–1.00 | <0.01 | 0.99 | 0.99–1.00 | 0.01 |
LVEF | 0.94 | 0.92–0.97 | <0.01 | 0.96 | 0.92–1.00 | 0.07 |
RVSP | 1.05 | 1.03–1.06 | <0.01 | 1.04 | 1.02–1.06 | <0.01 |
MR ≥ 2 | 1.41 | 0.92–2.17 | 0.11 | |||
AR ≥ 2 | 1.49 | 0.86–2.58 | 0.16 | |||
HF stage | 2.06 | 1.55–2.73 | <0.01 | 1.24 | 0.76–2.05 | 0.39 |
AF, atrial fibrillation; AR, aortic regurgitation; CI, confidence interval; DM, diabetes mellitus; HF, heart failure; HL, hyperlipidaemia; HT, hypertension; LV, left ventricular; LVEDV, left ventricular end‐diastolic volume; LVEF, left ventricular ejection fraction; MR, mitral regurgitation; OR, odds ratio; RVSP, right ventricular systolic pressure.
Those with P value < 0.05 were in bold which means the variable is significant.